An article from
News roundup
Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.
Published July 20, 2026
Getty Images
Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.
An article from
News roundup
Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.
Published July 20, 2026
Getty Images

Bristol Myers Squibb expands its Nvidia AI factory partnership, reporting 55% cost savings on drug discovery workloads. Here's…

Bristol Myers Squibb is the third drugmaker in nine months to announce it is building the largest AI supercomputer in the life…

Bristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug…

Bristol Myers says it will build biopharma's

Bristol Myers Squibb is the latest major drugmaker to tap Nvidia for more computing power, betting that larger models and AI…

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA